347 related articles for article (PubMed ID: 25047909)
1. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).
Łukaszewicz-Zając M; Mroczko B; Słowik A
J Neural Transm (Vienna); 2014 Nov; 121(11):1387-97. PubMed ID: 25047909
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases deregulation in amyotrophic lateral sclerosis.
Sánchez-Torres JL; Yescas-Gómez P; Torres-Romero J; Espinosa OR; Canovas LL; Tecalco-Cruz ÁC; Ponce-Regalado MD; Alvarez-Sánchez ME
J Neurol Sci; 2020 Dec; 419():117175. PubMed ID: 33068904
[TBL] [Abstract][Full Text] [Related]
4. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
5. [The role of metalloprotease in pathogenesis of nervous system diseases].
Mirowska D; Członkowska A
Neurol Neurochir Pol; 2001; 35(1):101-10. PubMed ID: 11464705
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods.
Sokolowska B; Jozwik A; Niebroj-Dobosz I; Janik P; Kwiecinski H
J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():117-20. PubMed ID: 20134051
[TBL] [Abstract][Full Text] [Related]
7. [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
Kurzepa J; Bartosik-Psujek H; Suchozebrska-Jesionek D; Rejdak K; Stryjecka-Zimmer M; Stelmasiak Z
Neurol Neurochir Pol; 2005; 39(1):63-7. PubMed ID: 15735992
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).
Lukaszewicz-Zając M; Mroczko B; Kornhuber J; Lewczuk P
J Neural Transm (Vienna); 2014 May; 121(5):469-77. PubMed ID: 24366530
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
10. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
Mroczko B; Groblewska M; Barcikowska M
J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.
Parrish AR
Prog Mol Biol Transl Sci; 2017; 148():31-65. PubMed ID: 28662825
[TBL] [Abstract][Full Text] [Related]
12. [Matrix metalloproteinases and their tissue inhibitors].
Trojanek J
Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinase alterations in the bone marrow of ALS patients.
Bossolasco P; Cova L; Calzarossa C; Servida F; Mencacci NE; Onida F; Polli E; Lambertenghi Deliliers G; Silani V
J Mol Med (Berl); 2010 Jun; 88(6):553-64. PubMed ID: 20091292
[TBL] [Abstract][Full Text] [Related]
14. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.
Herszényi L; Hritz I; Lakatos G; Varga MZ; Tulassay Z
Int J Mol Sci; 2012 Oct; 13(10):13240-63. PubMed ID: 23202950
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
[TBL] [Abstract][Full Text] [Related]
16. The TIMPs tango with MMPs and more in the central nervous system.
Crocker SJ; Pagenstecher A; Campbell IL
J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.
Zakiyanov O; Kalousová M; Zima T; Tesař V
Adv Clin Chem; 2021; 105():141-212. PubMed ID: 34809827
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
Maskos K; Bode W
Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
[TBL] [Abstract][Full Text] [Related]
19. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Groblewska M; Siewko M; Mroczko B; Szmitkowski M
Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
Bourboulia D; Stetler-Stevenson WG
Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
